BAYER AG
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Public
- Established
- 1863-08-01
- Employees
- 99.7K
- Market Cap
- $30.1B
- Website
- http://www.bayer.com
A Study to Learn About How BAY2927088 Affects the Level of Dabigatran or Rosuvastatin in the Blood When These Drugs Are Taken Together in Healthy Participants
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2024-03-26
- Last Posted Date
- 2024-07-05
- Lead Sponsor
- Bayer
- Target Recruit Count
- 15
- Registration Number
- NCT06329895
- Locations
- 🇬🇧
PAREXEL International Early Phase Clinical Unit (London), Harrow, United Kingdom
An Observational Study to Learn More About Treatment With Regorafenib in People With Advanced Gastrointestinal Stromal Tumors in the United States
Completed
- Conditions
- Interventions
- First Posted Date
- 2024-03-20
- Last Posted Date
- 2024-05-31
- Lead Sponsor
- Bayer
- Target Recruit Count
- 136
- Registration Number
- NCT06321055
- Locations
- 🇺🇸
Bayer, Whippany, New Jersey, United States
An Observational Study to Collect Data on How Aflibercept (Eylea) Given Using a Paediatric Dosing Device is Used in Preterm Babies With Retinopathy of Prematurity in the United Kingdom (UK)
- First Posted Date
- 2024-03-18
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- Bayer
- Target Recruit Count
- 200
- Registration Number
- NCT06315556
- Locations
- 🇬🇧
Many locations, Multiple Locations, United Kingdom
A First-in-Human Study to Learn How Well a Bi-Layer Calcium Carbonate Antacid Tablet Works Compared to a Standard, Non-Layered Calcium Carbonate Tablet in Healthy Male Participants
- First Posted Date
- 2024-03-05
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- Bayer
- Target Recruit Count
- 21
- Registration Number
- NCT06293326
- Locations
- 🇬🇧
BDD Pharma Bio-imaging Unit, Glasgow, United Kingdom
An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-02-26
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Bayer
- Target Recruit Count
- 50000
- Registration Number
- NCT06278207
- Locations
- 🇯🇵
Many Locations, Multiple Locations, Japan
🇩🇪Bayer, Berlin, Germany
An Observational Study to Learn More About How Safe Treatment With Rivaroxaban is in Children in Japan With Venous Thromboembolism
Completed
- Conditions
- Interventions
- First Posted Date
- 2024-02-26
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- Bayer
- Target Recruit Count
- 320
- Registration Number
- NCT06278051
- Locations
- 🇯🇵
Many facilities, Multiple Locations, Japan
🇯🇵Bayer, Osaka, Japan
An Observational Study to Identify New Health Problems Arising After an Intensive Care Unit Admission in People With Acute Respiratory Distress Syndrome in the United States
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-02-22
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- Bayer
- Target Recruit Count
- 140000
- Registration Number
- NCT06272942
- Locations
- 🇺🇸
Bayer, Whippany, New Jersey, United States
An Observational Study to Collect Information on the Safety of Gadolinium-Based Contrast Agents in Patients in India
- First Posted Date
- 2024-02-13
- Last Posted Date
- 2024-12-17
- Lead Sponsor
- Bayer
- Target Recruit Count
- 150
- Registration Number
- NCT06257277
- Locations
- 🇮🇳
Many locations, Multiple Locations, India
A Study of Continued Treatment With Regorafenib in Participants With Solid Tumors Who Have Participated in Other Bayer Studies
Phase 2
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-02-07
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Bayer
- Target Recruit Count
- 13
- Registration Number
- NCT06246643
- Locations
- 🇫🇷
Hôpital Paul Brousse - Villejuif, Villejuif, France
🇫🇷Hôpital Beaujon - Clichy, Clichy, France
🇫🇷Hôpital Claude Huriez - Lille, Lille, France
Expanded Access to Provide Copanlisib for Patients With Cancer Who Are Experiencing a Positive Response, as Determined by Their Doctors
- Conditions
- First Posted Date
- 2024-02-02
- Last Posted Date
- 2024-02-02
- Lead Sponsor
- Bayer
- Registration Number
- NCT06238583
- Locations
- 🇺🇦
Many Locations, Multiple Locations, Ukraine
© Copyright 2024. All Rights Reserved by MedPath